Suppliers / Aurisco Pharmaceutical Co.,Ltd

Aurisco Pharmaceutical Co.,Ltd

United States 605116.SS 34 employees 2 duplicate records merged Updated 9 July 2026

Aurisco Pharmaceutical Co.,Ltd is an API manufacturer based in United States. It holds 38 active US drug master files across a filed portfolio of 17 molecules. Its GMP standing is certified by MFDS (Korea).

38
active US DMFs
0
valid CEPs
0
registered plants
6
filings across 1 regulators

What they file, and where

Molecule Regulators Docs
Flumethasone US FDA 4
Fluticasone Propionate US FDA 4
Abiraterone SFDA (Saudi Arabia), US FDA 3
Apalutamide US FDA 2
Betamethasone US FDA 2
Brivaracetam US FDA 2
Budesonide US FDA 2
Darolutamide US FDA 2
Enzalutamide US FDA 2
Eplerenone US FDA 2
Show all 17 molecules on file
Finerenone US FDA 2
Fluticasone Furoate US FDA 2
Mometasone Furoate US FDA 2
Pregabalin US FDA 2
Relugolix US FDA 2
Tenofovir Alafenamide US FDA 2
Tenofovir Disoproxil US FDA 2

Also appears on these molecule pages

Betamethasone contract manufacturing Budesonide contract manufacturing Desogestrel contract manufacturing Dexamethasone contract manufacturing Drospirenone contract manufacturing Eplerenone contract manufacturing Mometasone contract manufacturing Prednisolone contract manufacturing Pregabalin contract manufacturing Semaglutide contract manufacturing Tenofovir Disoproxil API Fluticasone API

Filings and GMP by regulator

Regulator Filings GMP certificates
MINSA (CR) 6 None
MFDS (Korea) None 2

Comparing suppliers?

Choose your molecules and target markets. Aurisco Pharmaceutical Co.,Ltd comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates